FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Monica Bocchia

Research Profile

Procedures

Chemicals & Drugs

Concepts & Ideas

Disorders

Co-author Network

Publications

TOP 3
Marzia Defina; Alessandro Gozzetti; Antonella Gozzini; Micaela Ippoliti; Francesco Lauria; Gianantonio Rosti; Marzia Salvucci; Mario Tiribelli; Elisabetta Abruzzese; Lara Aprile; Claudia Baratè; Massimo Breccia; Fausto Castagnetti; Rosaria Crupi; Monica Bocchia
Evaluation of residual CD34(+) Ph(+) progenitor cells in chronic myeloid leukemia patients who have complete cytogenetic response during first-line nilotinib therapy.
Alessandro Gozzetti; Marzia Defina; Monica Bocchia
Lenalidomide maintenance in myeloma.
Alessandro Gozzetti; Giulia Papini; Marzia Defina; Monica Bocchia
Extramedullary myeloma relapses.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Monica Bocchia (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Marzia Defina; Alessandro Gozzetti; Antonella Gozzini; Micaela Ippoliti; Francesco Lauria; Gianantonio Rosti; Marzia Salvucci; Mario Tiribelli; Elisabetta Abruzzese; Lara Aprile; Claudia Baratè; Massimo Breccia; Fausto Castagnetti; Rosaria Crupi; Monica Bocchia
Evaluation of residual CD34(+) Ph(+) progenitor cells in chronic myeloid leukemia patients who have complete cytogenetic response during first-line nilotinib therapy.
Cancer 2012;118(21):5265-9.
2012: Alessandro Gozzetti; Marzia Defina; Monica Bocchia
Lenalidomide maintenance in myeloma.
Nature reviews. Clinical oncology 2012;9(10):.
2012: Alessandro Gozzetti; Giulia Papini; Marzia Defina; Monica Bocchia
Extramedullary myeloma relapses.
Annals of hematology 2012;91(9):1511-2.
2012: BRUNO JIM ROCCA; L Leoncini; M R Ambrosio; Monica Bocchia; Alessandro Gozzetti; Stefano Lazzi
Myeloid sarcoma and adenocarcinoma of the large bowel as collision tumors: a case report.
Histology and histopathology 2012;27(7):941-7.
2012: Alessandro Gozzetti; Pellegrino Musto; Giulia Papini; Teodora Steduto; Teodora Statuto; Giovanni D'Arena; Fiorella D'Auria; Marzia Defina; Monica Bocchia
Efficacy of bortezomib, lenalidomide and dexamethasone (VRD) in secondary plasma cell leukaemia.
British journal of haematology 2012;157(4):497-8.
2012: Alessandro Gozzetti; Alfonso CERASE; Marzia Defina; Monica Bocchia
Plasmacytoma of the skull.
European journal of haematology 2012;88(4):369.
2012: Micaela Ippoliti; Francesco Lauria; Alice Pietrini; Donatella Raspadori; Lara Aprile; Claudia Baratè; Marzia Defina; Alessandro Gozzetti; Antonella Gozzini; Monica Bocchia
Identification of a novel p190-derived breakpoint Peptide suitable for Peptide vaccine therapeutic approach in ph+ acute lymphoblastic leukemia patients.
Leukemia research and treatment 2012;2012():150651.
2012: Alessandro Gozzetti; Giulia Papini; Vania Rossi; Alfonso CERASE; Marzia Defina; Monica Bocchia
Single Agent Lenalidomide Activity in Multiple Myeloma Relapse Evidenced Uniquely by CT/PET.
Mediterranean journal of hematology and infectious diseases 2012;4(1):e2012041.
2011: Alessandro Gozzetti; Donatella Raspadori; Monica Bocchia; Alfonso CERASE; Rosaria Crupi; Marzia Defina; Francesco Lauria
A central nervous system CD56 positive multiple myeloma patient with a t(11;14) (q11;q32): a case report.
Leukemia research 2011;35(11):e206-8.
2011: Alessandro Gozzetti; Roberto Della Corte; Monica Bocchia; Giuseppe Coviello; Marzia Defina; Alberto Fabbri; Francesco Lauria
Unusual localizations of plasmacytoma.
Leukemia research 2011;35(7):e104-5.
2010: Alessandro Gozzetti; Marzia Defina; Monica Bocchia; Alberto Fabbri; Elena Marchini; Ida Chitarrelli; Francesco Lauria
Safety and efficacy of bortezomib, melphalan and low doses dexamethasone (VM-dex) in newly diagnosed patients with multiple myeloma.
Leukemia research 2010;34(11):e288-9.
2010: Monica Bocchia; Marzia Defina; Lara Aprile; Micaela Ippoliti; Rosaria Crupi; Michela Rondoni; Alessandro Gozzetti; Francesco Lauria
Complete molecular response in CML after p210 BCR-ABL1-derived peptide vaccination.
Nature reviews. Clinical oncology 2010;7(10):600-3.
2010: Francesco Zaja; Nicola Vianelli; Stefano Volpetti; Marta Lisa Battista; Marzia Defina; Salvatore Palmieri; Monica Bocchia; Marta Medeot; Stefano De Luca; Felicetto Ferrara; Miriam Isola; Michele Baccarani; Renato Fanin
Low-dose rituximab in adult patients with primary immune thrombocytopenia.
European journal of haematology 2010;85(4):329-34.
2010: Alessandro Gozzetti; Rosaria Crupi; Marzia Defina; Monica Bocchia
Lenalidomide efficacy in bortezomib-resistant myeloma.
Nature reviews. Clinical oncology 2010;7(9):.
2010: Alessandro Gozzetti; Alberto Fabbri; Marzia Defina; Ida Chitarrelli; Monica Bocchia
Hyperlipidemia in a myeloma patient after bortezomib treatment.
Leukemia research 2010;34(9):e250.
2010: Alessandro Gozzetti; Marzia Defina; Monica Bocchia; Francesco Lauria
Hyperlipidemic myeloma.
Annals of hematology 2010;89(9):939-40.
2010: Marzia Defina; A Gozzetti; M Rondoni; L Aprile; Micaela Ippoliti; I Chitarrelli; Francesco Lauria; Monica Bocchia
Very late relapse in a patient with chronic myeloid leukemia in sustained complete cytogenetic response under imatinib.
Leukemia research 2010;34(8):e215-6.
2010: Francesca Palandri; Fausto Castagnetti; Ilaria Iacobucci; Giovanni Martinelli; Marilina Amabile; Gabriele Gugliotta; Angela Poerio; Nicoletta Testoni; Massimo Breccia; Monica Bocchia; Monica Crugnola; Giovanna Rege-Cambrin; Bruno Martino; Ivana Pierri; Franca Radaelli; Giorgina Specchia; Fabrizio Pane; Giuseppe Saglio; Gianantonio Rosti; Michele Baccarani
The response to imatinib and interferon-alpha is more rapid than the response to imatinib alone: a retrospective analysis of 495 Philadelphia-positive chronic myeloid leukemia patients in early chronic phase.
Haematologica 2010;95(8):1415-9.
2010: Massimo Breccia; Monica Bocchia; Laura Cannella; Marzia Defina; Micaela Ippoliti; Giuseppina Loglisci; Michelina Santopietro; Francesco Lauria; Giuliana Alimena
Reduction of imatinib dose and persistence of complete molecular response after p210 multipeptide vaccine in chronic myeloid leukaemia treated with dose escalation for acquired resistance.
British journal of haematology 2010;150(2):240-2.
2010: Francesco Zaja; Michele Baccarani; Patrizio Mazza; Monica Bocchia; Luigi Gugliotta; Alfonso Zaccaria; Nicola Vianelli; Marzia Defina; Alessia Tieghi; Sergio Amadori; Selenia Campagna; Felicetto Ferrara; Emanuele Angelucci; Emilio Usala; Silvia Cantoni; Giuseppe Visani; Antonella Fornaro; Rita Rizzi; Valerio De Stefano; Francesco Casulli; Marta Lisa Battista; Miriam Isola; Franca Soldano; Enrica Gamba; Renato Fanin
Dexamethasone plus rituximab yields higher sustained response rates than dexamethasone monotherapy in adults with primary immune thrombocytopenia.
Blood 2010;115(14):2755-62.
2010: Alessandro Gozzetti; Alberto Fabbri; Stefania Oliva; Elena Marchini; Monica Bocchia; Marzia Defina; Francesco Lauria
Weekly bortezomib, pegylated liposomal doxorubicin, and dexamethasone is a safe and effective therapy for elderly patients with relapsed/refractory multiple myeloma.
Clinical lymphoma, myeloma & leukemia 2010;10(1):68-72.
2010: Alessandro Gozzetti; Rosaria Crupi; Michela Rondoni; Barbara Daviddi; Marzia Defina; Monica Bocchia; Alice Pietrini; Donatella Raspadori; Francesco Lauria
Translocation(X;2)(q26;q11.2) in a patient with acute myeloid leukemia M2 evolved from essential thrombocytemia.
Cancer genetics and cytogenetics 2010;197(1):84-5.
2010: Marzia Defina; Michela Rondoni; Alessandro Gozzetti; Lara Aprile; Ida Chitarrelli; Alberto Fabbri; Francesco Lauria; Monica Bocchia
Lenalidomide on alternative days is effective in myelodysplastic syndrome with 5q- deletion.
British journal of haematology 2010;148(3):483-4.
2010: Alessandro Gozzetti; Rosaria Crupi; Michela Rondoni; Marzia Defina; Monica Bocchia; Alice Pietrini; Donatella Raspadori; Francesco Lauria
A der(1)t(1;21)(p36.3;q22) in a patient with acute myelogenous leukemia M2.
Acta haematologica 2010;124(1):44-5.
2009: Alessandro Gozzetti; Marzia Defina; Monica Bocchia
Cutaneous myeloma and bortezomib.
Annals of hematology 2009;88(10):1045.
2009: Alessandro Gozzetti; Rosaria Crupi; Marzia Defina; Monica Bocchia; Donatella Raspadori; Francesco Lauria
Isolated deletion of 6q in a patient with myelodysplastic syndrome.
Cancer genetics and cytogenetics 2009;192(1):51.
2008: Francesca Palandri; Fausto Castagnetti; Nicoletta Testoni; Simona Luatti; Giulia Marzocchi; Simona Bassi; Massimo Breccia; Giuliana Alimena; Ester Pungolino; Giovanna Rege-Cambrin; Riccardo Varaldo; Maurizio Miglino; Giorgina Specchia; Elisa Zuffa; Felicetto Ferrara; Monica Bocchia; Giuseppe Saglio; Fabrizio Pane; Daniele Alberti; giovanni martinelli; Michele Baccarani; Gianantonio Rosti
Chronic myeloid leukemia in blast crisis treated with imatinib 600 mg: outcome of the patients alive after a 6-year follow-up.
Haematologica 2008;93(12):1792-6.
2008: Michele Malagola; Annalisa Peli; Daniela Damiani; Anna Candoni; Mario Tiribelli; giovanni martinelli; Pier Paolo Piccaluga; Stefania Paolini; Francesco De Rosa; Francesco Lauria; Monica Bocchia; marco gobbi; Ivana Pierri; Alfonso Zaccaria; Eliana Zuffa; Patrizio Mazza; Giancarla Priccolo; Luigi Gugliotta; Alessandro Bonini; Giuseppe Visani; Cristina Skert; Cesare Bergonzi; Aldo Maria Roccaro; Carla Filì; Renato Fanin; Michele Baccarani; Domenico Russo
Incidence of bacterial and fungal infections in newly diagnosed acute myeloid leukaemia patients younger than 65 yr treated with induction regimens including fludarabine: retrospective analysis of 224 cases.
European journal of haematology 2008;81(5):354-63.
2008: Francesco Zaja; Marta Lisa Battista; Maria Teresa Pirrotta; Salvatore Palmieri; Michela Montagna; Nicola Vianelli; Luciana Marin; Margherita Cavallin; Monica Bocchia; Marzia Defina; Micaela Ippoliti; Felicetto Ferrara; Francesca Patriarca; Maria Antonietta Avanzini; Mario Regazzi; Michele Baccarani; Miriam Isola; Franca Soldano; Renato Fanin
Lower dose rituximab is active in adults patients with idiopathic thrombocytopenic purpura.
Haematologica 2008;93(6):930-3.
2008: Maria Teresa Pirrotta; Alessandro Gozzetti; Alfonso CERASE; Alessandro Bucalossi; Monica Bocchia; Marzia Defina; Francesco Lauria
Unusual discordant responses in two multiple myeloma patients during bortezomib treatment.
Onkologie 2008;31(1-2):45-7.
2008: Monica Bocchia; Micaela Ippoliti; Alessandro Gozzetti; Elisabetta Abruzzese; Simona Calabrese; Marilina Amabile; Maria Teresa Pirrotta; Rosaria Crupi; Daniela Tozzuoli; Margherita M Trawinska; Marzia Defina; giovanni martinelli; Francesco Lauria
CD34+/Ph+ cells are still detectable in chronic myeloid leukemia patients with sustained and prolonged complete cytogenetic remission during treatment with imatinib mesylate.
Leukemia 2008;22(2):426-8.
2008: Alessandro Gozzetti; Monica Bocchia; Rosaria Crupi; Simona Calabrese; Maria Teresa Pirrotta; Donatella Raspadori; Marzia Defina; Renato Algeri; Francesco Lauria
Concomitant chronic myeloid leukemia and chronic lymphocytic leukemia: a different clonal origin shown by molecular cytogenetics.
Cancer genetics and cytogenetics 2008;180(1):83-4.
2007: Monica Bocchia; Alessandro M Vannucchi; Alessandro Gozzetti; Paola Guglielmelli; Giada Poli; Rosaria Crupi; Marzia Defina; Alberto Bosi; Lauria Francesco
Insights into JAK2-V617F mutation in CML.
The lancet oncology 2007;8(10):864-6.
2007: Alessandro Gozzetti; Simona Calabrese; Donatella Raspadori; Rosaria Crupi; Maristella Tassi; Monica Bocchia; Alberto Fabbri; Francesco Lauria
Concomitant t(4;11) and t(1;19) in a patient with biphenotypic acute leukemia.
Cancer genetics and cytogenetics 2007;177(1):81-2.
2007: Alessandro Gozzetti; Simona Calabrese; Rosaria Crupi; Daniela Tozzuoli; Alberto Fabbri; Monica Bocchia; Maria Teresa Pirrotta; Marzia Defina; Francesco Lauria
Deletion 9q in a patient with concomitant myelodysplasia and non-Hodgkin lymphoma.
Cancer genetics and cytogenetics 2007;175(2):177.
2007: Alessandro Gozzetti; Alfonso CERASE; Annachiara Tarantino; Alberto Fabbri; Monica Bocchia; Maria Teresa Pirrotta; Francesco Lauria
Multiple myeloma involving the cavernous sinus: a report of 3 cases and response to bortezomib.
Clinical lymphoma & myeloma 2007;7(5):376-8.
2007: Maria Teresa Pirrotta; Monica Bocchia; Alessandro Bucalossi; Marzia Defina; Francesco Forconi; Alessandro Gozzetti; Francesco Lauria
Pilot study of gemtuzumab ozogamicin (GO), fludarabine, cytarabine and idarubicin combined regimen (GO-FLAI) as first-line induction therapy plus GO alone as consolidation therapy for elderly acute myeloid leukemia patients.
Acta haematologica 2007;118(1):7-9.
2007: Alessandro Gozzetti; Monica Bocchia; Simona Calabrese; Maria Teresa Pirrotta; Rosaria Crupi; Donatella Raspadori; Francesco Lauria
Promyelocytic blast crisis of chronic myelogenous leukemia during imatinib treatment.
Acta haematologica 2007;117(4):236-7.
2007: Michele Malagola; Daniela Damiani; giovanni martinelli; Angela Michelutti; Bruno Cesana; Antonio De Vivo; Pier Paolo Piccaluga; Emanuela Ottaviani; Anna Candoni; Antonella Geromin; Mario Tiribelli; Renato Fanin; Nicoletta Testoni; Francesco Lauria; Monica Bocchia; marco gobbi; Ivana Pierri; Alfonso Zaccaria; Elisa Zuffa; Patrizio Mazza; Giancarla Priccolo; Luigi Gugliotta; Alessandro Bonini; Giuseppe Visani; Cristina Skert; Cesare Bergonzi; Aldo Roccaro; Carla Filí; Michele Baccarani; Domenico Russo
Case-control study of multidrug resistance phenotype and response to induction treatment including or not fludarabine in newly diagnosed acute myeloid leukaemia patients.
British journal of haematology 2007;136(1):87-95.
2006: Monica Bocchia; Francesco Forconi; Francesco Lauria
Emerging drugs in chronic myelogenous leukaemia.
Expert opinion on emerging drugs 2006;11(4):651-64.
2006: Serena Mazzotta; Roberto Guerranti; Alessandro Gozzetti; Alessandro Bucalossi; Monica Bocchia; Simona Sammassimo; Salvatore Petralia; Godwin Ifeanyi Ogueli; Francesco Lauria
Increased serum lactate dehydrogenase isoenzymes in Ph-negative chronic myeloproliferative diseases: a metabolic adaptation?
Hematology (Amsterdam, Netherlands) 2006;11(4):239-44.
2006: Alessandro Gozzetti; Simona Calabrese; Rosaria Crupi; Daniela Tozzuoli; Monica Bocchia; Alberto Fabbri; Maria Teresa Pirrotta; Simona Sammassimo; Marzia Defina; Francesco Lauria
Trisomy 22 as sole cytogenetic abnormality in acute monoblastic leukemia (M5b).
Cancer genetics and cytogenetics 2006;169(1):86.
2006: Alessandro Gozzetti; Rosaria Crupi; Daniela Tozzuoli; Simona Calabrese; Monica Bocchia; Maria Teresa Pirrotta; Donatella Raspadori; Francesco Lauria
Trisomy 13 in a patient with acute myeloid leukemia M0 and unusual durable remission.
Cancer genetics and cytogenetics 2006;167(2):182.
2006: Monica Bocchia; Elisabetta Abruzzese; Francesco Forconi; Micaela Ippoliti; Margherita M Trawinska; Maria Teresa Pirrotta; Donatella Raspadori; Monica Tozzi; Alessandro Gozzetti; Francesco Lauria
Imatinib does not impair specific antitumor T-cell immunity in patients with chronic myeloid leukemia.
Leukemia 2006;20(1):142-3.
2005: Serena Mazzotta; Alessandro Gozzetti; Maria Teresa Pirrotta; Monica Bocchia; Simona Sammassimo; Alessandro Bucalossi; Francesco Lauria
Low-dose thalidomide-induced agranulocytosis in a multiple myeloma patient treated at diagnosis.
Leukemia & lymphoma 2005;46(12):1837-8.
2005: Domenico Russo; Michele Malagola; Antonio de Vivo; Mauro Fiacchini; giovanni martinelli; Pier Paolo Piccaluga; Daniela Damiani; Anna Candoni; Angela Michielutti; Maurizio Castelli; Nicoletta Testoni; Emanuela Ottaviani; Michela Rondoni; Giancarla Pricolo; Patrizio Mazza; Elisa Zuffa; Alfonso Zaccaria; Donatella Raspadori; Monica Bocchia; Francesco Lauria; Alessandro Bonini; Paolo Avanzini; Luigi Gugliotta; Giuseppe Visani; Renato Fanin; Michele Baccarani
Multicentre phase III trial on fludarabine, cytarabine (Ara-C), and idarubicin versus idarubicin, Ara-C and etoposide for induction treatment of younger, newly diagnosed acute myeloid leukaemia patients.
British journal of haematology 2005;131(2):172-9.
2005: Maria Teresa Pirrotta; Alessandro Bucalossi; Francesco Forconi; Alessandro Gozzetti; Monica Bocchia; Serena Mazzotta; Simona Sammassimo; Francesco Lauria
Massive intravascular hemolysis: a fatal complication of Clostridium perfringens septicemia in a patient with acute lymphoblastic leukemia.
Leukemia & lymphoma 2005;46(5):793.
2005: Maria Teresa Pirrotta; Alessandro Bucalossi; Francesco Forconi; Monica Bocchia; Serena Mazzotta; Simona Sammassimo; Alessandro Gozzetti; Francesco Lauria
Thrombotic thrombocytopenic purpura secondary to an occult adenocarcinoma.
The oncologist 2005;10(4):299-300.
2005: Monica Bocchia; Sara Gentili; Elisabetta Abruzzese; A Fanelli; Franco Iuliano; A Tabilio; Marilina Amabile; Francesco Forconi; Alessandro Gozzetti; Donatella Raspadori; Sergio Amadori; Francesco Lauria
Effect of a p210 multipeptide vaccine associated with imatinib or interferon in patients with chronic myeloid leukaemia and persistent residual disease: a multicentre observational trial.
Lancet 2005;365(9460):657-62.
2005: Alessandro Gozzetti; Rosaria Crupi; Daniela Tozzuoli; Alberto Fabbri; Monica Bocchia; Francesco Lauria
Trisomy 13 in a patient with idiopathic myelofibrosis.
Cancer genetics and cytogenetics 2005;156(2):185.
2005: Michele Malagola; giovanni martinelli; Michela Rondoni; Stefania Paolini; Stavrula Gaitani; Mario Arpinati; Pier Paolo Piccaluga; Marilina Amabile; Constanza Basi; Emanuela Ottaviani; Anna Candoni; Enrico Gottardi; Daniela Cilloni; Monica Bocchia; Giuseppe Saglio; Francesco Lauria; Renato Fanin; Giuseppe Visani; Maria Carla Marrè; Michela Maderna; Francesca Rancati; Vincenza Vinaccia; Domenico Russo; Michele Baccarani
Imatinib mesylate in the treatment of c-kit-positive acute myeloid leukemia: is this the real target?
Blood 2005;105(2):904; author reply 905.
2004: Alessandro Gozzetti; Daniela Tozzuoli; Rosaria Crupi; Monica Bocchia; Serena Mazzotta; Donatella Raspadori; Francesco Lauria
A case of i(11)(q10) as sole cytogenetic abnormality in a patient with acute lymphoblastic leukemia.
Cancer genetics and cytogenetics 2004;154(2):193-4.
2004: Alessandro Gozzetti; Daniela Tozzuoli; Rosaria Crupi; Monica Bocchia; Serena Mazzotta; Francesco Lauria
Effect of 5637 conditioned medium (CM) on the mitotic index in the cytogenetic evaluation of myeloproliferative disorders.
Annales de génétique 2004;47(4):432-4.
2004: Alessandro Gozzetti; Daniela Tozzuoli; Rosaria Crupi; Albertina Fanelli; Sara Gentili; Monica Bocchia; Serena Mazzotta; Donatella Raspadori; Francesco Lauria
A novel t(6;7)(p24;q21) in a chronic myelocytic leukemia in complete cytogenetic remission after therapy with imatinib mesylate.
Cancer genetics and cytogenetics 2004;148(2):152-4.
2004: Simona Sammassimo; Serena Mazzotta; Monica Tozzi; Sara Gentili; Mariapia Lenoci; Rosa Santopietro; Alessandro Bucalossi; Monica Bocchia; Francesco Lauria
Disseminated mucormycosis in a patient with acute myeloblastic leukemia misdiagnosed as infection by Enterococcus faecium.
Journal of clinical microbiology 2004;42(1):487-9.
2003: Alessandro Gozzetti; Daniela Tozzuoli; Rosaria Crupi; Sara Gentili; Monica Bocchia; Donatella Raspadori; Francesco Lauria
Emergence of Ph negative clones in chronic myeloid leukemia (CML) patients in complete cytogenetic remission after therapy with imatinib mesylate (STI).
European journal of haematology 2003;71(4):313-4.
2003: Monica Bocchia; Sara Gentili; Francesco Forconi; Mariapia le Noci; Monica Tozzi; Francesco Lauria
Low-grade non Hodgkin's lymphomas in the elderly: impact of a low-dose fludarabine-based combination regimen (mini-FLEC).
Haematologica 2003;88(3):358-60.
2002: Monica Bocchia
Is there any role left for p210-derived peptide vaccines in chronic myeloid leukemia?
Haematologica 2002;87(7):675-7.
2001: Francesco Lauria; Mariapia Lenoci; Luciana Annino; Donatella Raspadori; Giuseppe Marotta; Monica Bocchia; Francesco Forconi; Sara Gentili; M La Manda; S Marconcini; Monica Tozzi; Luca Baldini; Pier Luigi Zinzani; Robin Foà
Efficacy of anti-CD20 monoclonal antibodies (Mabthera) in patients with progressed hairy cell leukemia.
Haematologica 2001;86(10):1046-50.
2001: Pier Luigi Zinzani; Maurizio Martelli; Maurizio Bendandi; Amalia De Renzo; Alfonso Zaccaria; E Pavone; Monica Bocchia; Brunangelo Falini; marco gobbi; Filippo Gherlinzoni; Vittorio Stefoni; Monica Tani; Sante Tura
Primary mediastinal large B-cell lymphoma with sclerosis: a clinical study of 89 patients treated with MACOP-B chemotherapy and radiation therapy.
Haematologica 2001;86(2):187-91.
2000: Giuseppe Marotta; C Bigazzi; Mariapia Lenoci; Monica Tozzi; Monica Bocchia; Francesco Lauria
Low-dose fludarabine and cyclophosphamide in elderly patients with B-cell chronic lymphocytic leukemia refractory to conventional therapy.
Haematologica 2000;85(12):1268-70.
2000: Monica Bocchia; V Bronte; M P Colombo; A de Vincentiis; M Di Nicola; G Forni; L Lanata; Roberto M Lemoli; Massimo Massaia; Damiano Rondelli; P Zanon; Sante Tura
Antitumor vaccination: where we stand.
Haematologica 2000;85(11):1172-206.
2000: Daniele Laszlo; Piero Galieni; Donatella Raspadori; G Scalia; C Bigazzi; Monica Bocchia; Alessandro Bucalossi; Giuseppe Marotta; Monica Tozzi; Francesco Lauria
Fludarabine containing-regimens may adversely affect peripheral blood stem cell collection in low-grade non Hodgkin lymphoma patients.
Leukemia & lymphoma 2000;37(1-2):157-61.
1999: Pier Luigi Zinzani; M Magagnoli; Luciano Moretti; R Battista; F Ronconi; Amalia De Renzo; Alfonso Zaccaria; Paolo Gentilini; Luciano Guardigni; Filippo Gherlinzoni; Claudia Cellini; Patrizia Fattori; Maurizio Bendandi; Monica Bocchia; E Aitini; Sante Tura
Fludarabine-based chemotherapy in untreated mantle cell lymphomas: an encouraging experience in 29 patients.
Haematologica 1999;84(11):1002-6.
1999: Pier Luigi Zinzani; Maurizio Martelli; M Magagnoli; Francesco Zaja; Sergio Storti; E Pavone; Vito Michele Lauta; Amalia De Renzo; marco gobbi; Monica Bocchia; F Ronconi; Laura Scaramucci; Filippo Gherlinzoni; Fioretta Palombi; Maurizio Bendandi; Vittorio Stefoni; P Anticoli Borza; Claudia Cellini; Franco Mandelli; Sante Tura
How do patients with aggressive non-Hodgkin's lymphoma treated with third-generation regimens (MACOP-B and F-MACHOP) fare in the long-term?
Haematologica 1999;84(11):996-1001.
1999: Francesco Forconi; Monica Bocchia; S Marconcini; C Bigazzi; M Milani; G Fraternali-Orcioni; Francesco Lauria
CD30 positive (non-anaplastic) peripheral T-cell lymphoma of the thyroid gland.
Haematologica 1999;84(10):946-8.
1999: Monica Bocchia; C Bigazzi; S Marconcini; Francesco Forconi; Giuseppe Marotta; Renato Algeri; Francesco Lauria
Favorable impact of low-dose fludarabine plus epirubicin and cyclophosphamide regimen (FLEC) as treatment for low-grade non-Hodgkin's lymphomas.
Haematologica 1999;84(8):716-20.
1999: Pier Luigi Zinzani; Sergio Storti; Alfonso Zaccaria; Luciano Moretti; M Magagnoli; E Pavone; Paolo Gentilini; Luciano Guardigni; marco gobbi; Patrizia Fattori; Brunangelo Falini; Vito Michele Lauta; Maurizio Bendandi; Filippo Gherlinzoni; Amalia De Renzo; Francesco Zaja; Patrizio Mazza; Ettore Volpe; Monica Bocchia; E Aitini; Michela Tabanelli; Giuseppe Leone; Sante Tura
Elderly aggressive-histology non-Hodgkin's lymphoma: first-line VNCOP-B regimen experience on 350 patients.
Blood 1999;94(1):33-8.
1999: Francesco Lauria; Monica Bocchia; Giuseppe Marotta; Donatella Raspadori; Pier Luigi Zinzani; Damiano Rondelli
Weekly administration of 2-chlorodeoxyadenosine in patients with hairy-cell leukemia is effective and reduces infectious complications.
Haematologica 1999;84(1):22-5.
1998: Giuseppe Marotta; C Bigazzi; Monica Bocchia; Francesco Forconi; Francesco Lauria
Long-term follow-up of non-Hodgkin's lymphoma patients treated with ProMACE-CytaBOM: an effective regimen for the intermediate grade subtype.
Haematologica 1998;83(9):853-4.
1998: Pier Luigi Zinzani; Maurizio Martelli; M Magagnoli; Alfonso Zaccaria; F Ronconi; Maria Cantonetti; Monica Bocchia; R Marra; marco gobbi; Brunangelo Falini; Filippo Gherlinzoni; Luciano Moretti; Amalia De Renzo; Patrizio Mazza; E Pavone; Elena Sabattini; A Amendola; Maurizio Bendandi; Stefano A Pileri; Franco Mandelli; Sante Tura
Anaplastic large cell lymphoma Hodgkin's-like: a randomized trial of ABVD versus MACOP-B with and without radiation therapy.
Blood 1998;92(3):790-4.
1998: Giuseppe Marotta; Alessandro Bucalossi; Piero Galieni; C Bigazzi; S Nuti; P E Valenzin; Monica Bocchia; Francesco Lauria
CD4+/CD45RA+ 'naive' T cells and immunological response to influenza virus vaccine in B-cell chronic lymphocytic leukaemia patients.
Acta haematologica 1998;99(1):18-21.
1997: Francesco Lauria; Damiano Rondelli; Pier Luigi Zinzani; Monica Bocchia; Giuseppe Marotta; M Salvucci; Donatella Raspadori; MA Ventura; S Birtolo; Francesco Forconi; Sante Tura
Long-lasting complete remission in patients with hairy cell leukemia treated with 2-CdA: a 5-year survey.
Leukemia 1997;11(5):629-32.
1997: Francesco Lauria; Monica Bocchia; Giuseppe Marotta; Donatella Raspadori; Pier Luigi Zinzani; Damiano Rondelli
Weekly administration of 2-chlorodeoxyadenosine in patients with hairy-cell leukemia: a new treatment schedule effective and safer in preventing infectious complications.
Blood 1997;89(5):1838-9.
1995: Patrizio Mazza; Pier Luigi Zinzani; Maurizio Martelli; M Fiacchini; Monica Bocchia; S Pileri; Brunangelo Falini; M F Martelli; Sergio Amadori; G Papa
MACOP-B vs F-MACHOP regimen in the treatment of high-grade non-Hodgkin's lymphomas.
Leukemia & lymphoma 1995;16(5-6):457-63.
1994: S Pileri; Monica Bocchia; C D Baroni; M Martelli; B Falini; Elena Sabattini; F Gherlinzoni; S Amadori; S Poggi; P Mazza
Anaplastic large cell lymphoma (CD30 +/Ki-1+): results of a prospective clinico-pathological study of 69 cases.
British journal of haematology 1994;86(3):513-23.
1993: S Pileri; Brunangelo Falini; S Poggi; Monica Benni; Monica Bocchia; G Melilli; Elena Sabattini; P L Tazzari; H Stein
[Considerations in Hodgkin's disease].
Pathologica 1993;85(1099):445-66.
1993: Pier Luigi Zinzani; Francesco Lauria; Damiano Rondelli; D Benfenati; Donatella Raspadori; Monica Bocchia; Alessandro Gozzetti; Michele Cavo; T M Cirio; Francesco Zaja
Fludarabine in patients with advanced and/or resistant B-chronic lymphocytic leukemia.
European journal of haematology 1993;51(2):93-7.
1993: Pier Luigi Zinzani; Francesco Lauria; Damiano Rondelli; D Benfenati; Donatella Raspadori; Monica Bocchia; Maurizio Bendandi; Alessandro Gozzetti; Francesco Zaja; Renato Fanin
Fludarabine: an active agent in the treatment of previously-treated and untreated low-grade non-Hodgkin's lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1993;4(7):575-8.
1992: Patrizio Mazza; Monica Bocchia; Pier Luigi Zinzani; M Fiacchini; Filippo Gherlinzoni; Giuseppe Bandini; Maurizio Bendandi; Giovanni P Frezza; Stefano Neri; Enza Barbieri
Hodgkin's disease: summary of twenty years' experience.
Haematologica 1992;77(6):487-93.
1992: Pier Luigi Zinzani; Patrizio Mazza; Filippo Gherlinzoni; Monica Bocchia; M Fiacchini; Maurizio Bendandi; Enza Barbieri; Giovanni P Frezza; Stefano Neri; E Aitini
Massive mediastinal involvement in stage I-II Hodgkin's disease: response to combined modality treatment.
Leukemia & lymphoma 1992;8(1-2):81-5.
1992: Pier Luigi Zinzani; Patrizio Mazza; Filippo Gherlinzoni; Monica Bocchia; Maurizio Bendandi; M Fiacchini; Sante Tura
"Very late" relapses in Hodgkin's disease patients: a rare but real phenomenon.
Haematologica 1992;77(5):435-7.
1992: Patrizio Mazza; Monica Bocchia; Fabio Tumietto; Paolo Costigliola; Olga V Coronado; Giuseppe Bandini; Roberto Conte; E Ricchi; Nicola Vianelli; E Raise
Recombinant interleukin-2 (rIL-2) in acquired immune deficiency syndrome (AIDS): preliminary report in patients with lymphoma associated with HIV infection.
European journal of haematology 1992;49(1):1-6.
1991: Patrizio Mazza; Monica Bocchia; S Tura; Fabio Tumietto; Paolo Costigliola; Olga V Coronado; E Ricchi; Francesco Chiodo
Evidence for beneficial effect of recombinant interleukin-2 in HIV-associated B lymphoma.
AIDS (London, England) 1991;5(9):1141-2.
1991: Pier Luigi Zinzani; M Fiacchini; Patrizio Mazza; Filippo Gherlinzoni; Monica Bocchia; Sante Tura
Fifteen-year experience in Hodgkin's disease: role of combined modality treatment and splenectomy in the incidence of secondary acute leukemia.
Haematologica 1991;76(4):305-10.
1991: Pier Luigi Zinzani; Patrizio Mazza; Filippo Gherlinzoni; R Zanchini; Monica Bocchia; Sante Tura
Mycosis fungoides: a therapeutical review.
Haematologica 1991;76(2):150-61.
1991: Filippo Gherlinzoni; Patrizio Mazza; Monica Bocchia; Pier Luigi Zinzani; M Fiacchini; R Zanchini; S Pileri; Sante Tura
Stage I high-grade non-Hodgkin's lymphomas: a retrospective analysis.
Haematologica 1991;76(1):38-42.
1991: Pier Luigi Zinzani; Francesco Lauria; Donatella Raspadori; M Buzzi; D Benfenati; Monica Bocchia; Damiano Rondelli; Sante Tura
Comparison of low-dose versus standard-dose alpha-interferon regimen in the hairy cell leukemia treatment.
Acta haematologica 1991;85(1):16-9.
1991: Sante Tura; Franco Mandelli; Patrizio Mazza; S Pileri; Filippo Gherlinzoni; Monica Bocchia; Pier Luigi Zinzani; M Fiacchini; Maurizio Martelli; G Papa
MACOP-B vs F-MACHOP in the treatment of high-grade non-Hodgkin's lymphomas.
Leukemia 1991;5 Suppl 1():74-8.
1991: Patrizio Mazza; Monica Bocchia; R Zanchini; Filippo Gherlinzoni; Pier Luigi Zinzani; S Pileri; Sante Tura
MN (N = Novantrone) COP-B therapy on high and intermediate grade non-Hodgkin's lymphoma: an alternative to MA (A = adriamycin) COP-B?
Haematologica 1991;76(1):47-52.
1990: Pier Luigi Zinzani; Patrizio Mazza; Filippo Gherlinzoni; R Zanchini; Monica Bocchia; E Aitini; Giovanna Cavazzini; B Amurri; marco gobbi; Sante Tura
CEOP regimen in the treatment of advanced low-grade non-Hodgkin's lymphomas: preliminary report.
Tumori 1990;76(6):533-6.
1990: Patrizio Mazza; Monica Bocchia; Pier Luigi Zinzani; Filippo Gherlinzoni; P L Ghetti
[Rational basis for the use of alfa-2a recombinant interferon in the treatment of mycosis fungoides (MF)].
Haematologica 1990;75 Suppl 4():78-81.
1990: Pier Luigi Zinzani; Francesco Lauria; M Buzzi; Donatella Raspadori; Luigi Gugliotta; Monica Bocchia; S Macchi; R Algeri; Sante Tura
Hairy cell leukemia variant: a morphologic, immunologic and clinical study of 7 cases.
Haematologica 1990;75(1):54-7.
1990: Francesco Lauria; Pier Luigi Zinzani; Donatella Raspadori; R Foà; M Buzzi; Luigi Gugliotta; Monica Bocchia; D Benfenati; Sante Tura
Relationship between immunological phenotype and hematological response to alpha-IFN treatment in 35 patients with hairy cell leukemia.
European journal of haematology. Supplementum 1990;52():3-6.
1990: P Mazza; Sante Tura; Monica Bocchia; Pier Luigi Zinzani; F Gherlinzoni; F Mandelli; M P Anselmo; G Papa; M Antimi; P G Gobbi
Alpha-2b recombinant interferon (Intron) in Hodgkin's lymphoma: therapeutic perspective.
European journal of haematology. Supplementum 1990;52():22-4.